Bacterial Vaginosis (Gardnerella vaginalis)
For the why behind the fact
Use this page to connect what you are memorizing.
Start with the overview when a class slide, Anki card, or qbank explanation feels too thin. Then use presentation and workup to recognize the condition, and differentials to separate look-alikes.
Overview
Plain-Language Overview
Bacterial vaginosis (BV) is an imbalance of vaginal bacteria. Protective lactobacilli decrease while several other bacteria, often including Gardnerella, increase. It may cause thin discharge and a fishy odor, though many people have no symptoms. BV is associated with increased STI and pregnancy-complication risks; appropriate antibiotics can treat symptomatic episodes, but recurrence is common.
Clinical Definition
BV is polymicrobial vaginal dysbiosis, often with a Gardnerella-containing biofilm, reduced lactobacilli and pH above 4.5. It causes thin malodorous discharge with usually little visible inflammation, and is frequently asymptomatic. Gardnerella detection alone does not establish BV. Sexual exchange of associated bacteria contributes to recurrence, but the initiating microbiome changes are not fully understood.
Inciting Event
Sexual activity can exchange BV-associated bacteria between partners; this does not prove an outside sexual exposure or infidelity.
Douching and other intravaginal practices can disturb the microbiome; BV does not have one obligatory trigger.
Hormonal changes such as those during menstruation or pregnancy altering vaginal pH.
Latency Period
There is no fixed incubation period for this dysbiosis; symptoms may appear, fluctuate or remain absent.
There may be a variable asymptomatic period before clinical presentation.
Diagnostic Delay
Symptoms are often mild or absent, leading to underreporting.
Misattribution to yeast infection or other vaginitis delays correct diagnosis.
Lack of routine microscopic examination or use of inappropriate tests can delay diagnosis.
Clinical Presentation
Signs & Symptoms
Thin, homogenous vaginal discharge that is gray or white in color is the hallmark symptom.
Fishy vaginal odor often worsens after intercourse due to alkaline semen altering vaginal pH.
Mild vaginal itching or irritation may be present but is less common than in candidiasis.
History of Present Illness
Patients commonly report thin, gray-white vaginal discharge with a fishy odor especially after intercourse.
Vaginal itching or irritation is usually mild or absent.
Symptoms may fluctuate with the menstrual cycle and worsen after sexual activity or douching.
Past Medical History
History of recurrent bacterial vaginosis or other vaginal infections increases risk.
Prior use of broad-spectrum antibiotics can predispose to flora disruption.
Use of intrauterine devices or recent gynecologic procedures may be relevant.
Family History
There is no well-established heritable pattern or familial syndrome associated with bacterial vaginosis.
Family history is generally not contributory to risk or presentation.
Physical Exam Findings
Thin, gray-white vaginal discharge coating the vaginal walls is characteristic of bacterial vaginosis.
Vaginal mucosa appears normal without significant erythema or edema, distinguishing it from infectious vaginitis.
Fishy odor is often noted when the discharge is present, especially after adding potassium hydroxide (KOH).
Diagnostic Workup
Diagnostic Criteria
Diagnosis of bacterial vaginosis is established using Amsel criteria, requiring at least three of the following: a homogeneous, thin, grayish vaginal discharge, vaginal pH greater than 4.5, a positive whiff test (fishy odor on adding KOH), and the presence of clue cells on microscopic examination of vaginal fluid. Alternatively, the Nugent score from Gram stain of vaginal smear quantifies bacterial morphotypes, with a score of 7-10 confirming BV. These diagnostic methods focus on identifying the characteristic bacterial imbalance and clinical features.
Pathophysiology
Key Mechanisms
Loss of a lactobacillus-dominant, acidic environment accompanies expansion of a mixed bacterial community, often including Gardnerella and other anaerobes.
Increased vaginal pH (>4.5) facilitates proliferation of anaerobic bacteria and reduces protective acidic environment.
Production of amines by anaerobic bacteria causes the characteristic fishy odor and alters vaginal secretions.
Biofilm formation by Gardnerella vaginalis on vaginal epithelial cells promotes bacterial persistence and resistance to host defenses.
| Involvement | Details |
|---|---|
| Organs | Vagina is the organ involved, where the imbalance of normal flora leads to bacterial vaginosis and its clinical manifestations. |
| Tissues | Vaginal mucosa is the primary tissue affected in bacterial vaginosis, showing disruption of normal lactobacilli-dominated flora. |
| Cells | Clue cells are vaginal squamous epithelial cells coated with adherent bacteria, obscuring their borders; epithelial destruction is not the defining finding. |
Usually few inflammatory leukocytes are seen relative to inflammatory vaginitis. Marked leukocytosis suggests a concurrent or alternative condition. | |
| Chemical Mediators | Volatile amines produced by anaerobic bacteria cause the characteristic fishy odor in bacterial vaginosis. |
pH elevation in vaginal secretions above 4.5 promotes overgrowth of Gardnerella vaginalis and other anaerobes. |
Treatments
Pharmacological Treatments
Metronidazole
- Mechanism:
Disrupts DNA synthesis in anaerobic bacteria including Gardnerella vaginalis by forming toxic metabolites.
- Side effects:
Metallic taste
Nausea
Alcohol interaction is disputed: CDC found no convincing disulfiram-like evidence, but oral product labels still advise avoiding alcohol/propylene glycol during treatment and for at least 3 days afterward. Follow product-specific counseling.
- Clinical role:
Recommended symptomatic-BV options: 500 mg orally twice daily for 7 days, or 0.75% vaginal gel, 5 g daily for 5 days. Oral or vaginal treatment can be used in pregnancy when indicated.
Clindamycin
- Mechanism:
Inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, effective against anaerobic bacteria.
- Side effects:
Diarrhea
Clostridioides difficile colitis
Allergic reactions
- Clinical role:
2% vaginal cream, 5 g at bedtime for 7 days is a recommended regimen; oral clindamycin is an alternative. Oil-based cream can impair latex barriers for 5 days afterward; other products have different warnings.
Non-pharmacological Treatments
Avoidance of douching to maintain normal vaginal flora and prevent disruption of the vaginal microbiome.
During treatment, abstain or use an appropriate barrier; vaginal clindamycin can weaken some barrier products, so check the formulation-specific instructions.
Prevention
Pharmacological Prevention
For multiple recurrences, clinician-directed 0.75% metronidazole gel twice weekly for more than 3 months may reduce episodes; benefit can fade after stopping.
Clindamycin cream treats BV but is not an established routine maintenance regimen. Recurrent symptomatic BV may warrant concurrent partner treatment under updated guidance.
Routine antibiotics are not indicated for every asymptomatic patient. Treat symptomatic pregnancy-associated BV; screening asymptomatic pregnant patients solely to prevent preterm birth is not routinely recommended.
Non-pharmacological Prevention
Avoidance of douching to preserve normal vaginal flora and prevent disruption of protective lactobacilli.
Use of condoms to reduce exposure to semen and sexually transmitted pathogens that alter vaginal pH.
Discuss recurrence and ongoing partners. 2025 ACOG/2026 guidance supports considering concurrent partner treatment, especially for recurrent symptomatic BV; evidence is strongest for combined oral/topical treatment of ongoing male partners.
Outcome & Complications
Complications
Increased susceptibility to HIV infection due to disruption of normal vaginal flora and mucosal barrier.
BV is associated with PID; isolated vaginal BV is not itself a diagnosis of upper-genital-tract infection.
Postoperative infections such as endometritis after gynecologic surgeries or procedures.
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Bacterial Vaginosis (Gardnerella vaginalis) versus Vulvovaginal Candidiasis
Bacterial Vaginosis (Gardnerella vaginalis) | Vulvovaginal Candidiasis |
|---|---|
Polymicrobial imbalance with predominance of Gardnerella vaginalis and anaerobes | Overgrowth of Candida albicans or other Candida species |
Clue cells on saline wet mount with positive whiff test | Budding yeast/hyphae or pseudohyphae may be seen, usually with pH below 4.5. C. glabrata lacks hyphae; negative microscopy does not exclude candidiasis. |
Thin, homogenous, grayish vaginal discharge with fishy odor | Intense vulvar pruritus and thick, curd-like vaginal discharge |
Bacterial Vaginosis (Gardnerella vaginalis) versus Trichomoniasis
Bacterial Vaginosis (Gardnerella vaginalis) | Trichomoniasis |
|---|---|
Bacterial overgrowth dominated by Gardnerella vaginalis | Infection with motile Trichomonas vaginalis protozoa |
Clue cells support BV; trichomoniasis can coexist. | Motile organisms may appear on a fresh wet mount, but sensitivity is limited; NAAT is more sensitive. pH is often elevated in both conditions. |
Thin, grayish vaginal discharge with minimal vulvar irritation | Frothy, yellow-green vaginal discharge with vulvar irritation |
Bacterial Vaginosis (Gardnerella vaginalis) versus Chlamydia trachomatis Infection
Bacterial Vaginosis (Gardnerella vaginalis) | Chlamydia trachomatis Infection |
|---|---|
Polymicrobial bacterial imbalance with Gardnerella vaginalis predominance | Intracellular gram-negative obligate intracellular bacterium Chlamydia trachomatis |
Clue cells/combined BV criteria; a negative chlamydia test is not required, because coinfection is possible. | Positive nucleic acid amplification test (NAAT) for Chlamydia trachomatis |
Typically malodorous vaginal discharge without cervical inflammation | Often asymptomatic or mucopurulent cervical discharge with possible pelvic pain |
Bacterial Vaginosis (Gardnerella vaginalis) versus Gonorrhea
Bacterial Vaginosis (Gardnerella vaginalis) | Gonorrhea |
|---|---|
Polymicrobial bacterial imbalance dominated by Gardnerella vaginalis | Infection with gram-negative diplococcus Neisseria gonorrhoeae |
Combined BV criteria; a negative gonorrhea test is not required, because coinfection is possible. | Positive culture or NAAT for Neisseria gonorrhoeae |
Thin, homogenous vaginal discharge without cervical purulence | Purulent cervical discharge and possible pelvic inflammatory disease |
Bacterial Vaginosis (Gardnerella vaginalis) versus Atrophic Vaginitis
Bacterial Vaginosis (Gardnerella vaginalis) | Atrophic Vaginitis |
|---|---|
Most common during reproductive years but not restricted to a particular estrogen level. | Estrogen deficiency after menopause or in other hypoestrogenic states. |
Malodorous, thin vaginal discharge with minimal irritation | Dryness, burning, dyspareunia and thin/friable mucosa; discharge can occur, and concurrent infection is possible. |
Presence of clue cells and decreased lactobacilli | Often elevated pH, reduced lactobacilli and parabasal-cell predominance. This is not simply normal flora; low lactobacilli alone cannot distinguish it from BV. |